IPC The Hospitalist Company’s “Neutral” Rating Reaffirmed at Credit Suisse (IPCM)
IPC The Hospitalist Company (NASDAQ:IPCM)‘s stock had its “neutral” rating restated by research analysts at Credit Suisse in a report released on Wednesday. They currently have a $42.00 target price on the stock, down from their previous target price of $50.00. Credit Suisse’s price objective would suggest a potential upside of 8.14% from the stock’s previous close.
IPC The Hospitalist Company (NASDAQ:IPCM) traded up 0.15% during mid-day trading on Wednesday, hitting $38.90. The stock had a trading volume of 97,237 shares. IPC The Hospitalist Company has a 1-year low of $38.13 and a 1-year high of $63.70. The stock has a 50-day moving average of $41.96 and a 200-day moving average of $50.62. The company has a market cap of $666.4 million and a price-to-earnings ratio of 16.46.
IPC The Hospitalist Company (NASDAQ:IPCM) last released its earnings data on Wednesday, April 23rd. The company reported $0.57 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.64 by $0.07. The company had revenue of $172.73 million for the quarter, compared to the consensus estimate of $183.00 million. During the same quarter in the previous year, the company posted $0.57 earnings per share. The company’s revenue for the quarter was up 12.8% on a year-over-year basis. On average, analysts predict that IPC The Hospitalist Company will post $2.40 earnings per share for the current fiscal year.
IPCM has been the subject of a number of other recent research reports. Analysts at Wells Fargo & Co. upgraded shares of IPC The Hospitalist Company from a “market perform” rating to an “outperform” rating in a research note on Friday, April 25th. Separately, analysts at Citigroup Inc. reiterated a “hold” rating on shares of IPC The Hospitalist Company in a research note on Thursday, April 24th. They now have a $50.00 price target on the stock. Finally, analysts at Deutsche Bank reiterated a “hold” rating on shares of IPC The Hospitalist Company in a research note on Thursday, April 24th. They now have a $51.00 price target on the stock, down previously from $54.00. Seven investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $52.25.
IPC The Hospitalist Company, Inc (NASDAQ:IPCM) is a provider of hospitalist services in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.